The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
The toxicology of aflatoxins as a basis for public health decisions
Open accessAbstract
Aflatoxins have been extensively studied with respect to their mechanisms of toxicity. An understanding of metabolism, DNA adduct induction, mutagenicity and carcinogenicity has been paralleled by the development of biomarkers of aflatoxin exposure and biological effects (e.g. mutations) applied to human populations. The improvements in exposure assessment and their application in prospective epidemiological studies and the demonstration of a specific mutation in the TP53 gene in hepatocellular carcinomas from areas of high aflatoxin exposure have contributed significantly to the classification of aflatoxins as human carcinogens. In addition to establishing the carcinogenicity of aflatoxins in humans, understanding molecular mechanisms of action has provided the scientific rationale for prevention strategies, including primary and chemoprevention approaches. Overall, integrated, multidisciplinary research on aflatoxins has provided the platform on which to base decisions regarding acceptable exposures and priorities for interventions to reduce human risk in a public health context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,162
Some traditional herbal medicines, some mycotoxins, naphthalene and styrene.
Anttila, A., Bhat, R. V., Bond, J. A., Borghoff, S. J., Bosch, F. X., Carlson, G. P., Castegnaro, M., Cruzan, G., Gelderblom, W. C. A., Hass, U., et al. (2002) · PubMed · Cited by 1,674
Self-citationMutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Mechanisms of Aflatoxin Carcinogenesis
Eaton, D. L., & Gallagher, E. P. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001031 · Cited by 774
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
The genetic determinants of the CYP3A5 polymorphism
Hustert, E., Haberl, M., Burk, O., Wolbold, R., He, Y.-Q., Klein, K., Nuessler, A. C., Neuhaus, P., Klattig, J., Eiselt, R., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200112000-00005 · Cited by 673
Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J., Gao, Y. T., Henderson, B. E., Wogan, G. N., & Groopman, J. D. (1994) · PubMed · Cited by 666
The toxicology of aflatoxins: human health, veterinary and agricultural significance.
Eaton, D. L., & Groopman, J. D. (1993) · Cited by 597
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis
Smela, M. E., Currier, S. S., Bailey, E. A., & Essigmann, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.535 · Cited by 362
Activation and detoxication of aflatoxin B1
Guengerich, F. P., Johnson, W. W., Shimada, T., Ueng, Y.-F., Yamazaki, H., & Langouët, S. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00289-3 · Cited by 344
Wang, J.-S., Shen, X., He, X., Zhu, Y.-R., Zhang, B.-C., Wang, J.-B., Qian, G.-S., Kuang, S.-Y., Zarba, A., Egner, P. A., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.347 · Cited by 307
Egner, P. A., Wang, J.-B., Zhu, Y.-R., Zhang, B.-C., Wu, Y., Zhang, Q.-N., Qian, G.-S., Kuang, S.-Y., Gange, S. J., Jacobson, L. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251536898 · Cited by 301
Puisieux, A., Lim, S.-K., Groopman, J. D., & Öztürk, M. (1991) · PubMed · Cited by 298
Base substitution mutations induced by metabolically activated aflatoxin B1.
Foster, P. L., Eisenstadt, E., & Miller, J. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2695 · Cited by 274
Hepatocellular Carcinoma: From Gene to Public Health
Montesano, R., Hainaut, P., & Wild, C. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1844 · Cited by 269
Self-citationGallagher, E. P., Kunze, K. L., Stapleton, P. L., & Eaton, D. L. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0326 · Cited by 267
Cellular interactions and metabolism of aflatoxin: An update
McLean, M., & Dutton, M. F. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00054-7 · Cited by 262
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
Wang, L.-Y., Hatch, M., Chen, C.-J., Levin, B., You, S.-L., Lu, S.-N., Wu, M.-H., Wu, W.-P., Wang, L.-W., Wang, Q., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5<620::aid-ijc5>3.0.co;2-w · Cited by 259
p53 gene mutation spectrum in hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 250
Sabbioni, G., Skipper, P. L., Büchi, G., & Tannenbaum, S. R. (1987) · Carcinogenesis · doi:10.1093/carcin/8.6.819 · Cited by 245
Primary prevention of hepatocellular carcinoma in developing countries
Wild, C. P., & Hall, A. J. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00027-2 · Cited by 226
Self-citationOxidation of Aflatoxin B1 by Bacterial Recombinant Human Cytochrome P450 Enzymes
Ueng, Y.-F., Shimada, T., Yamazaki, H., & Guengerich, F. P. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00044a006 · Cited by 216
Raney, K. D., Meyer, D. J., Ketterer, B., Harris, T. M., & Guengerich, F. P. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00028a004 · Cited by 191
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
Kirk, G. D., Camus-Randon, A.-M., Mendy, M., Goedert, J. J., Merle, P., Trépo, C., Bréchot, C., Hainaut, P., & Montesano, R. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.148 · Cited by 190
Groopman, J. D., Donahue, P. R., Zhu, J. Q., Chen, J. S., & Wogan, G. N. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6492 · Cited by 181
Lunn, R. M., Zhang, Y. J., Wang, L., Chen, C., Lee, P., Lee, C. S., Tsai, W. Y., & Santella, R. M. (1997) · PubMed · Cited by 170
Kensler, T. W., Egner, P. A., Davidson, N. E., Roebuck, B. D., Pikul, A., & Groopman, J. D. (1986) · PubMed · Cited by 166
Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey, E. A., Iyer, R. S., Stone, M. P., Harris, T. M., & Essigmann, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1535 · Cited by 165
Roebuck, B. D., Liu, Y. L., Rogers, A. E., Groopman, J. D., & Kensler, T. W. (1991) · PubMed · Cited by 162
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., & Ishizaki, K. (1993) · PubMed · Cited by 162
Scorsone, K. A., Zhou, Y. Z., Butel, J. S., & Slagle, B. L. (1992) · PubMed · Cited by 162
Environmental and genetic determinants of aflatoxin-albumin adducts in The Gambia
Wild, C. P., Yin, F., Turner, P. C., Chemin, I., Chapot, B., Mendy, M., Whittle, H., Kirk, G. D., & Hall, A. J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<1::aid-ijc1>3.0.co;2-i · Cited by 160
Self-citationLangouët, S., Coles, B. C., Morel, F., et al. (1995) · PubMed · Cited by 152
The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight?
Groopman, J. D., & Kensler, T. W. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.1 · Cited by 140
Dashwood, R. H., Negishi, T., Hayatsu, H., Breinholt, V. M., Hendricks, J. D., & Bailey, G. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00259-5 · Cited by 136
Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K., & Maeda, S. (1994) · PubMed · Cited by 135
Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice.
Sell, S., Hunt, J. M., Dunsford, H. A., & Chisari, F. V. (1991) · PubMed · Cited by 135
Wang, J., Qian, G., Zarba, A., He, X., Zhu, Y. R., Zhang, B.-C., Jacobson, L. P., Gange, S. J., Muñoz, Á., & Kensler, T. W. (1996) · PubMed · Cited by 135
Kensler, T. W., He, X., Otieno, M. A., Egner, P. A., Jacobson, L. P., Chen, B., Wang, J., Zhu, Y., Zhang, B.-C., Wang, J. B., et al. (1998) · PubMed · Cited by 129
Soini, Y., Chia, S.-C., Bennett, W. P., Groopman, J. D., Wang, J.-S., DeBenedetti, V. M. G., Cawley, H., Welsh, J.-A., Hansen, C., Bergasa, N. V., et al. (1996) · Carcinogenesis · doi:10.1093/carcin/17.5.1007 · Cited by 128
Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., & Sugimachi, K. (1993) · PubMed · Cited by 123
Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wang, N. J., Xie, J. P., & Thorgeirsson, S. S. (1994) · PubMed · Cited by 123
Wang, H., Dick, R. A., Yin, H., Licad-Coles, E., Kroetz, D. L., Szklarz, G. D., Harlow, G. R., Halpert, J. R., & Correia, M. A. (1998) · Biochemistry · doi:10.1021/bi980895g · Cited by 120
Hayes, J. D., Judah, D. J., & Neal, G. E. (1993) · PubMed · Cited by 117
Jacobson, L. P., Zhang, B. C., Zhu, Y. R., Wang, J. B., Wu, Y., Zhang, Q. N., Yu, L., Qian, G., Kuang, S. Y., Li, Y. F., et al. (1997) · PubMed · Cited by 116
Hayes, J. D., Judah, D. J., McLellan, L. I., Kerr, L. A., Peacock, S. D., & Neal, G. E. (1991) · Biochemical Journal · doi:10.1042/bj2790385 · Cited by 115
Stern, M. C., Umbach, D. M., Yu, M. C., London, S. J., Zhang, Z., & Taylor, J. A. (2001) · PubMed · Cited by 112
Morel, F., Fardel, O., Meyer, D. J., Langouët, S., Gilmore, K. S., Meunier, B., Tu, C. D., Kensler, T. W., KETTERER, B., & Guillouzo, A. (1993) · PubMed · Cited by 110
In-utero exposure to aflatoxin in West Africa
Wild, C. P., Rasheed, F. N., Jawla, M., Hall, A. J., Jansen, L. A. M., & Montesano, R. (1991) · The Lancet · doi:10.1016/0140-6736(91)93295-k · Cited by 109
Self-citationBenasutti, M., Ejadi, S., Whitlow, M. D., & Loechler, E. L. (1988) · Biochemistry · doi:10.1021/bi00401a068 · Cited by 106
Jackson, P. E., Qian, G., Friesen, M. D., Zhu, Y. R., Lu, P., Wang, J. B., Wu, Y., Kensler, T. W., Vogelstein, B., & Groopman, J. D. (2001) · PubMed · Cited by 105
Denissenko, M. F., Koudriakova, T. B., Smith, L. G., O'Connor, T. R., Riggs, A. D., & Pfeifer, G. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202214 · Cited by 104
Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
Forrester, K., Lupold, S. E., Ott, V. L., Chay, C. H., Band, V., Wang, X. W., & Harris, C. C. (1995) · PubMed · Cited by 100
p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from thailand
Hollstein, M. C., Wild, C. P., Bleicher, F., Chutimataewin, S., Harris, C. C., Srivatanakul, A., & Montesano, R. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530111 · Cited by 98
Self-citationAnalysis of the P53 Tumor–Suppressor Gene in Hepatocellular Carcinomas From Britain
Challen, C., Lunec, J., Warren, W., Collier, J. D., & Bassendine, M. F. (1992) · Hepatology · doi:10.1002/hep.1840160610 · Cited by 98
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children
Allen, S. J., Wild, C. P., Wheeler, J. G., Riley, E. M., Montesano, R., Bennett, S., Whittle, H., Hall, A. J., & Greenwood, B. M. (1992) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(92)90253-9 · Cited by 96
Self-citationPonchel, F., Puisieux, A., Tabone, É., Michot, J., Fröschl, G., Morel, A., Frébourg, T., Fontanière, B., Oberhammer, F., & Öztürk, M. (1994) · PubMed · Cited by 95
Hayes, J. D., Judah, D. J., Neal, G. E., & Nguyen, T. H. (1992) · Biochemical Journal · doi:10.1042/bj2850173 · Cited by 95
Johnson, W. W., Harris, T. M., & Guengerich, F. P. (1996) · Journal of the American Chemical Society · doi:10.1021/ja960525k · Cited by 94
Levy, D. D., Groopman, J. D., Lim, S. E., Seidman, M. M., & Kraemer, K. H. (1992) · Cancer Research · Cited by 92
Groopman, J. D., DeMatos, P., Egner, P. A., Love-Hunt, A., & Kensler, T. W. (1992) · Carcinogenesis · doi:10.1093/carcin/13.1.101 · Cited by 92
Vautier, G., Bomford, A. B., Portmann, B. C., Metivier, E. M., Williams, R. L., & Ryder, S. D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70562-7 · Cited by 88
p53 Mutations in human hepatocellular carcinomas from Germany.
Kress, S., Jahn, U.-R., Buchmann, A., Bannasch, P., & Schwarz, M. (1992) · PubMed · Cited by 88
Sun, C., Chen, H., Lu, S., Chen, C., Lu, C., You, S., & Lin, S. (2001) · Journal of Medical Virology · doi:10.1002/jmv.1097 · Cited by 87
Ireland, L. S., Harrison, D. J., Neal, G. E., & Hayes, J. D. (1998) · Biochemical Journal · doi:10.1042/bj3320021 · Cited by 86
Gopalakrishnan, S., Harris, T. M., & Stone, M. P. (1990) · Biochemistry · doi:10.1021/bi00498a002 · Cited by 85
Buetow, K. H., Sheffield, V. C., Zhu, M., Zhou, T., Shen, F. M., Hino, O., Smith, M. A., McMahon, B. J., Lanier, A., & London, W. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9622 · Cited by 83
Biotransformation of aflatoxin B1 in human lung
Donnelly, P. J., Stewart, R. K., Ali, S. L., Conlan, A. A., Reid, K. R., Petsikas, D., & Massey, T. E. (1996) · Carcinogenesis · doi:10.1093/carcin/17.11.2487 · Cited by 82
Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild, C. P., Hasegawa, R., Barraud, L., Chutimataewin, S., Chapot, B., Ito, N., & Montesano, R. (1996) · PubMed · Cited by 78
Self-citationRaney, V. M., Harris, T. M., & Stone, M. P. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00031a010 · Cited by 77
Buetler, T. M., & Eaton, D. L. (1992) · PubMed · Cited by 71
Bourdon, J., D’Errico, A., Paterlini-Bréchot, P., Grigioni, W., May, E., & Debuire, B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90217-1 · Cited by 68
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono, S., Chou, M. J., Lee, C., et al. (1993) · PubMed · Cited by 68
Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.
Fujimoto, Y., Hampton, L. L., Luo, L., Wirth, P. J., & Thorgeirsson, S. S. (1992) · PubMed · Cited by 67
Denissenko, M. F., Cahill, J. M., Koudriakova, T. B., Gerber, N., & Pfeifer, G. P. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00038-x · Cited by 66
Sohn, S. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00010-0 · Cited by 65
Zhou, T., Evans, A. A., London, W. T., Xia, X., Zou, H., Shen, F., & Clapper, M. L. (1997) · PubMed · Cited by 58
Genetic Changes and Histopathological Grades in Human Hepatocellular Carcinomas
Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Sato, C., Tsuruta, K., Maeda, Y., Koike, M., Tanaka, S., Nakamura, Y., Hattori, N., et al. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02063.x · Cited by 56
Sylla, A., Diallo, M. S., Castegnaro, J.-J., & Wild, C. P. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s1383-5742(99)00046-0 · Cited by 56
Self-citationp53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
Ng, I. O., Chung, L. P., Tsang, S. W. Y., Lam, C.-W., Lai, E. C. S., Fan, S. T., & NG, M. M. (1994) · PubMed · Cited by 56
Kensler, T. W., Gange, S. J., Egner, P. A., Dolan, P. M., Muñoz, Á., Groopman, J. D., Rogers, A. E., & Roebuck, B. D. (1997) · PubMed · Cited by 53
Trottier, Y., Waithe, W. I., & Anderson, A. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060209 · Cited by 51
Dumenco, L. L., Oguey, D., Wu, J. C., Messier, N. J., & Fausto, N. (1995) · Hepatology · doi:10.1016/0270-9139(95)90640-1 · Cited by 51
Park, U. S., Su, J. J., Ban, K. C., et al. (2000) · Gene · doi:10.1016/s0378-1119(00)00183-9 · Cited by 50
Adenine Adduct of Aflatoxin B1 Epoxide
Iyer, R. S., Voehler, M., & Harris, T. M. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00099a001 · Cited by 47
Chen, S., Chen, C., Chou, S.-R., Hsieh, L., Wang, L., Tsai, W., Ahsan, H., & Santella, R. M. (2001) · PubMed · Cited by 42
Kubicka, S., Trautwein, C., Schrem, H., Tillmann, H. L., & Manns, M. P. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80199-5 · Cited by 37
Heinonen, J. T., Fisher, R. L., Brendel, K., & Eaton, D. L. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0001 · Cited by 35
Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line
Stettler, P. M., & Sengstag, C. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1047 · Cited by 34
Chemin, I., Takahashi, S., Belloc, C., Lang, M. A., Ando, K., Guidotti, L. G., Chisari, F. V., & Wild, C. P. (1996) · Hepatology · doi:10.1002/hep.510240330 · Cited by 30
Self-citationp53 Abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons
Kazachkov, Y., Khaoustov, V. I., Yoffe, B., et al. (1996) · Carcinogenesis · doi:10.1093/carcin/17.10.2207 · Cited by 30
Banerjee, R., Caruccio, L., Zhang, Y. J., McKercher, S. R., & Santella, R. M. (2000) · Hepatology · doi:10.1053/jhep.2000.9197 · Cited by 25
Chomarat, P., Rice, J. M., Slagle, B. L., & Wild, C. P. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00254-9 · Cited by 23
Self-citationRivkina, M., Cullen, J. M., Robinson, W. S., & Marion, P. L. (1994) · PubMed · Cited by 22
Li, Y., Su, J.-J., Qin, L. L., Egner, P. A., Wang, J.-S., Groopman, J. D., Kensler, T. W., & Roebuck, B. D. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00382-7 · Cited by 22
Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: Lack of association
Hsieh, D. P. H., & Atkinson, D. N. (1995) · Food Additives & Contaminants · doi:10.1080/02652039509374324 · Cited by 19
Dumenco, L. L., Oguey, D., Wu, J. C., Messier, N. J., & Fausto, N. (1995) · Hepatology · doi:10.1002/hep.1840220438 · Cited by 17
Etiology of cancer in humans and animals
Wild, C. P., & Kleihues, P. (1996) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(96)80029-7 · Cited by 10
Self-citationp53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Wild, C. P. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0456 · Cited by 2,562
Self-citationMycotoxins and human disease: a largely ignored global health issue
Wild, C. P., & Gong, Y. Y. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp264 · Cited by 981
Self-citationBryden, W. L. (2012) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2011.12.014 · Cited by 725
Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology
Kensler, T. W., Roebuck, B. D., Wogan, G. N., & Groopman, J. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq283 · Cited by 703
“For example, it is now well established that aflatoxin exposure begins in utero and increases markedly as a child is weaned onto solid family foods (Wild and Turner, 2002).”
BackgroundAllocati, N., Masulli, M., Di Ilio, C., & Federici, L. (2018) · Oncogenesis · doi:10.1038/s41389-017-0025-3 · Cited by 625
Metadata
- Authors
- Wild, C. P.
- Venue
- Mutagenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11-01
- Volume
- 17
- Issue
- 6
- Pages
- 471-481
- ISSN
- 0267-8357 (ISSN-L)
- 1464-3804
- OpenAlex
- W2160566428
- Cited by
- 475
- References
- 103
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.